Baclofen is used to treat muscle spasms caused by alcoholism and to control or lessen the frequency and severity of alcohol-related side effects. Baclofen is also used to treat anxiety caused by brain or spinal cord injury, cerebral palsy, Parkinson's disease, multiple sclerosis, or spinal cord injuries. Baclofen also may be used to treat muscle spasms caused by cerebral palsy.
Baclofen may cause side effects. Common side effects include headache, nervousness, flushing, and stomach upset. These side effects may occur in up to 1 in 10 people, and include:
If you experience any of the following side effects while taking Baclofen, stop taking it and see your doctor immediately:
Before using Baclofen, consult your doctor if you have a history of severe kidney disease or liver disease, or if you are taking other drugs that affect the brain or spinal cord. Baclofen may cause drowsiness and dizziness. To avoid these effects, drive or operate machinery, and avoid hazardous activities, take Baclofen exactly as prescribed by your doctor. Your doctor may need to monitor you for any signs or symptoms of drowsiness or dizziness. Baclofen can cause drowsiness, drowsiness, and dizziness.
If you miss a dose of Baclofen, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take extra doses to make up for a missed dose.
Store Baclofen at room temperature, between 68-77° F (20-25° C). Keep this medicine out of reach of children.
Side effects may occur while taking Baclofen. Common side effects include:
Before taking Baclofen, consult your doctor if you have a history of severe kidney disease or liver disease. Baclofen may cause drowsiness, drowsiness, and dizziness.
References|Baclofen Tablets 20 mg by Teva a muscle relaxer and an antispastic agent. Baclofen is used to treat muscle symptoms caused by multiple sclerosis, including spasm, pain, and stiffness. Baclofen may also be used for purposes not listed in this medication guide.
Each tablet, for oral administration, contains 20 mg baclofen, USP. In addition, each tablet contains the following inactive ingredients: anhydrous lactose, colloidal silicon dioxide, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal cord diseases.
Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.
The efficacy of baclofen in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions.
Brand: Teva PharmaceuticalsSize: 100 TabletsStrength: 20 mgNDC: 00172-4097-60UPC: 301724097605
Buy Baclofen Tablets 20 mg by Teva used to treat muscle symptoms caused by multiple sclerosis at Mountainside Medical Equipment.
Buy Baclofen Tablets 20 mg by Teva used to treat muscle symptoms caused by multiple sclerosis at Mountainside Medical Equipment TevaManufactured by Teva Pharmaceuticals, a privately held specialty pharmaceutical company. We offer a comprehensive range of Baclofen tablets and solutions. Each tablet contains 20 mg baclofen. Each solution contains 20 mg baclofen.
Baclofen tablets 20 mg by Teva are a muscle relaxer and an antispastic agent that inhibits skeletal muscle protein synthesis by binding to and preventing the binding of sodium to the 50S subunit of voltage- and calcium-chiraxis. The inhibitory action of Baclofen blocks the binding of these chemicals to nerve cells, resulting in muscle spasms and involuntary muscle contractions. Baclofen works by preventing the binding of sodium to the 50S subunit of voltage- and calcium-chiraxis, allowing increased muscle tone and resulting in increased spasticity. Baclofen tablets are indicated for the relief of pain, muscular rigidity, and spasms caused by multiple sclerosis, particularly in patients who do not respond well to other available antispasmodic agents, such as antimuscarinic agents. The efficacy of Baclofen in stroke, cerebral palsy, and Parkinson's disease has not been established and therefore, it is not recommended for these conditions.
Baclofen tablets 20 mg by Teva are indicated for the relief of pain, muscle spasms, and spasm associated with multiple sclerosis. Baclofen tablets are indicated in the treatment of multiple sclerosis, particularly in patients who do not respond well to other available antispasmodic agents and are not receiving effective treatment.
Baclofen tablets 20 mg by Teva is contraindicated in patients with a known hypersensitivity to baclofen, other excipients, or to any of the excipients listed in this medication guide.
Pregnancy and breastfeeding should be considered when using Baclofen tablets. Baclofen tablets are excreted in breast milk and should be administered with caution in nursing infants. Baclofen tablets are excreted in breast milk but the amount of drug absorbed through the infant should be carefully monitored. Baclofen tablets are excreted in breast milk only and should be administered with caution in nursing infants. Baclofen tablets are excreted in breast milk without the need for any other treatment.
The most common adverse reactions of Baclofen tablets 20 mg by Teva are somnolence (nausea), sedation, decreased muscle tone, dysgeusia, cramps, and weakness.
The global baclofen market was valued at USD 3.42 billion in 2023 and is projected to reach USD 4.61 billion by 2033, growing at a CAGR of 7.6% from 2022 to 2033[1].
The market is dominated by muscle relaxers such as methylprednisolone (MDR), butylprednisolone (ABPI), and tetracaine[2].
The high demand in the muscle relaxers market can be ameliorated by strategic initiatives such as automation of healthcare and enhanced patient retention[3].
Another factor to take into account is the growing incidence of diabetes, high blood pressure, and stroke in patients globally[4][5].
In addition, advancements in healthcare technologies and ongoing research into chemotherapy and anti-emetic therapies are driving the market growth bothOlder market players are focusing on expanding their product portfolios and growing their product portfolioso As of 2026, the global baclofen market size was estimated at USD 126.5 million, growing at a CAGR of 8.6% from 2022 to 2033[1].]
This growth reflects the ongoing evolution of pharmaceutical industry and the increasing demand for effective treatments[2].
| Seg load for the baclofen Segment Analysis[4] | Q1% Formulation Types | Quamura[5] | Summary of Form Fs of Baclofen | |
|---|---|---|---|---|
| Market Segment | Market Analysis | |||
| Treatment Fs | Treatment Groups | |||
| Application Fs | Application Efavirenz | Efficacy Groups | ||
| Region Fs | North America | Europe | Asia-Pacific | South-East Asia |
| Shared Market Share | Outper ratio | 1.50 | 0.50 | 0.49 |
| Segmental Share | Lumpur Global Market Size - 2025 ilexant - 5.75 ills/ml | Cleveland0iaspan Global Market Size - 5.0 ills/ml | Columbia Global Market Size - 5.5 ills/ml |
The baclofen market is segmented based on several key factors, including treatment type, market size, demand growth, and industryational players (e.g., [1], [2]).
The increasing incidence of diabetes, a big driver for the market is the increasing prevalence of overweight and obesity, especially in developing countries[3].
One of the key drivers of the baclofen market is the Affordability and Patient Awarenesscaring of the drug. Patients often want the treatment option to improve their quality of life and quality of lifefor longer treatment. For instance, patients often need to choose between long-term treatment and a daily routine[4].
Technological advancements, such as the introduction of automation in healthcare and the introduction of electronic medical prescriptions, are also driving the demand for baclofen[4].
Regulatory budgets are significant factors in the baclofen market, especially for generic and branded medications. Generic baclofen is typically more affordable and is typically less expensive than the brand name version[2].
The global Baclofen oral tablet market was valued at USD 1.8 billion in 2023 and is projected to reach USD 2 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.6% from 2024 to 2031[1].
The rising prevalence of mental health disorders, such as schizophrenia, bipolar disorder, and conduct disorders, is a major driver of the market[1][3].
Studies have also highlighted the growing acceptance of healthcare infrastructure with healthcare prices increasing globally, such as in China, which further boosts market growth[4].
The increasing demand for mental health treatments, such as Baclofen, in countries like China, India, and certain regions, contributes to market growth. This is attributed to improved healthcare infrastructure and increased healthcare expenditure. This growth is attributed to increasing healthcare spending and the adoption of rapid action plans to address mental health concerns[4].
Recent advancements in pharmaceutical formulations, such as intravenous (IV) formulations and topical formulations, further boost market growth. This expansion is attributed to improved formulations and reduced side effects associated with IV formulations[4].
The Baclofen oral tablet market is experiencing a shift towards cash prices, contributing to market dynamics favourable for revenue growth. As the cost of the drug rises, the price may increase the likelihood of lower reimbursement levels due to price competition and higher profit margins[1][3].
Baclofen is a gamma-aminobutyric acid (GABA) agonist used to treat muscle spasms caused by multiple sclerosis, multiple myeloma, and leukemia. It can help improve muscle function and reduce inflammation, which is key for recovery and recovery during surgery[3][5].
Regulatory regulations surrounding Baclofen oral tablet production and distribution, such as stringent regulations in China and India, limit its application to the pharmaceutical sector. This poses significant financial challenges for the market[1].
The introduction of generic versions of Baclofen has led to a significant increase in price competition, thus posing a threat to market profitability[1][3].
Regulatory compliance across various pharmaceutical products significantly reduces market prices and ensures market access. This Compliance Excessive Use (CKER) strategy helps protect consumers from generic Baclofen products, thereby lowering therapeutic costs and ensuring product quality[3].
While Baclofen is generally well-tolerated, it can cause side effects such as headache, nausea, dizziness, and insomnia. These side effects are usually mild and temporary but can be serious for some individuals[1].
Regulatory environments across various pharmaceutical products, such as stringent regulatory policies and stringent patient safety standards, pose significant challenges for the market. This unregulated sector poses significant regulatory risk, which is particularly harmful for healthcare providers[1].
Q: What is the current market size of the global Baclofen oral tablet market?A: The global Baclofen oral tablet market was valued at USD 1.8 billion in 2023[1].
Stade de France Pharmacy